What Is an AI Assurance Lab, the CHAI Model, and How Health Systems Use Them
An AI assurance lab is an independent or semi-independent validation function that evaluates healthcare AI models against defined technical, clinical, and governance criteria before or after deployment. In the CHAI model healthcare AI discussion, the central idea is a coalition-oriented approach to model assurance: health systems should not rely only on a vendor’s internal testing, but should use shared evaluation practices, documented findings, and governance review to assess whether a model is safe, fair, performant, and fit for its intended use.
What an AI assurance lab is
An AI assurance lab is a validation function for healthcare AI models. It may be independent or semi-independent, and it evaluates models against defined technical, clinical, and governance criteria before or after deployment.
The purpose is to give health systems a more structured basis for decision-making than vendor documentation alone. The assurance process can assess whether a model is safe, fair, performant, and fit for its intended use.
Where an AI assurance lab fits
Assurance is most useful when its findings are connected to the decisions a health system must make across the AI lifecycle.
Before purchase
Review model evidence, intended use, validation scope, and independence before procurement decisions.
Before deployment
Assess whether model performance, subgroup behavior, and workflow fit are acceptable for the local context.
After deployment
Use runtime monitoring and governance controls to detect drift, policy violations, or context changes.
How the CHAI model frames healthcare AI assurance
In the CHAI model healthcare AI discussion, the central idea is a coalition-oriented approach to model assurance. Health systems should not rely only on a vendor’s internal testing. They should use shared evaluation practices, documented findings, and governance review to assess whether a model is safe, fair, performant, and fit for its intended use.
This framing makes AI assurance part of a broader governance process. It creates a shared way to review evidence, document findings, and connect those findings to deployment decisions.
How health systems use assurance lab findings
Assurance lab findings can inform procurement, credentialing, deployment approval, and re-validation decisions. They help governance leaders evaluate whether a model should be purchased, approved for a specific use case, or reviewed again after meaningful changes.
| Decision point | How assurance findings help | What still requires governance |
|---|---|---|
| Procurement | Review model evidence, intended use, validation scope, and independence before a purchase decision. | Determine whether the model aligns with the health system’s policies, risk tolerance, and intended operational context. |
| Deployment approval | Assess whether model performance, subgroup behavior, and workflow fit are acceptable for the local context. | Define who can use the model, what the model is allowed to do, and what controls apply after go-live. |
| Re-validation | Support review when retraining, vendor updates, new use cases, or significant population changes occur. | Maintain a system of record for model versions, policies, runtime events, and audit evidence. |
A practical AI model assurance testing workflow
A practical AI model assurance testing workflow should make the evaluation scope, evidence, and governance handoff clear enough for downstream decision-making.
Define the intended use
Clarify the model’s intended use, the clinical or operational context, and the decision the assurance review is meant to inform.
Evaluate the model evidence
Review model evidence, validation scope, technical criteria, clinical criteria, governance criteria, and independence before relying on the findings.
Assess local fit
Assess whether model performance, subgroup behavior, and workflow fit are acceptable for the health system’s local context.
Connect findings to operating controls
Use runtime monitoring and governance controls to detect drift, policy violations, or context changes after deployment.
The gap between assurance validation and runtime governance
A central limitation of assurance lab validation is that it is usually point-in-time or periodic. It can answer whether a model met defined criteria under a specific evaluation scenario. It cannot, by itself, prove that the model will continue to behave appropriately in a live clinical environment.
Runtime conditions change. Patient populations shift, clinical documentation patterns evolve, upstream data feeds change, and vendors may update model behavior. A model can also fail because of workflow integration rather than statistical performance alone. For example, clinicians may over-rely on a recommendation, ignore a warning because it appears too often, or use a model outside its intended scope. These issues are difficult to resolve through pre-deployment assurance alone.
For that reason, health systems need a governance architecture that connects assurance outputs to runtime controls. At a minimum, the organization should know which AI systems are deployed, which policies apply, what the model is allowed to do, what data or tools it may access, which users or agents can invoke it, and what events are logged for audit review.
For AI agents, this extends into agent identity, permissions, least privilege, tool approval workflows, MCP security where applicable, and agent-to-agent security.
Assurance and runtime governance are complementary. An assurance lab can help establish whether a model is acceptable for a defined purpose, while runtime governance helps enforce policies, monitor behavior, maintain audit logs, and control how AI agents interact with tools and enterprise systems after deployment.
Trussed AI focuses on runtime governance and security for enterprise AI agents. In this context, an assurance lab can help establish whether a model is acceptable for a defined purpose, while runtime governance helps enforce policies, monitor behavior, maintain audit logs, and control how AI agents interact with tools and enterprise systems after deployment. These are complementary functions. Assurance supports entry decisions. Runtime governance supports operating control.
Questions governance leaders should ask before relying on an AI assurance lab
- What exact model version, configuration, and dataset were evaluated?
- Does the assurance environment resemble the intended clinical or operational deployment context?
- Were subgroup performance, bias, and fairness considerations evaluated for populations relevant to the health system?
- What documentation will be received, and can it be stored in the AI inventory or governance system of record?
- What events require re-validation, such as retraining, vendor updates, new use cases, or significant population changes?
- Is the assurance lab independent of the vendor, and are any funding or governance relationships disclosed?
Summary
AI assurance labs can improve pre-deployment confidence by evaluating models against defined technical, clinical, and governance criteria. The CHAI model healthcare AI discussion emphasizes shared evaluation practices, documented findings, and governance review instead of relying only on a vendor’s internal testing.
Those findings can inform procurement, credentialing, deployment approval, and re-validation decisions. They do not replace continuous runtime monitoring once an AI model is live in clinical or operational workflows.
Connect assurance findings to runtime AI governance
AI assurance labs can improve pre-deployment confidence, but health systems still need runtime controls, monitoring, policy enforcement, and auditability once AI systems and agents are live.
Explore Runtime Governance